StocksFin Logo
ABCL logo
$ABCL

AbCellera Biologics Inc.

ABCL country of incorporation
|
https://www.abcellera.com
|
Dr. Carl L. Hansen
|
475 employees
NASDAQ | Healthcare | Biotechnology
ABCL reported its Q322 earnings on November 8, 2022 (76 weeks ago).
$101.38M 1740.6% vs. Q321 Revenues Q322
85.17% -14.8% vs. Q321 Gross Profit Margin
26.26% 106.8% vs. Q321 Net Profit Margin
-141.3M ! -874.1% vs. Q321 Free Cash Flow Q322
$0.09 212.5% vs. Q321 EPS Q322
Company Card Q322
As reported on November 8, 2022
Is profitable?
Has Revenue Growth?
Has Net Profit Growth?
Has FCF Growth?
Has OCF Growth?
Has EPS Growth?
Pays a Dividend?
Rating
B+
Growth calculated YoY
Company Card Q322
As reported on November 8, 2022
Is profitable?
Has Revenue Growth?
Has Net Profit Growth?
Has FCF Growth?
Has OCF Growth?
Has EPS Growth?
Pays a Dividend?
Rating
B+
Growth calculated YoY
Overview
Income Statement
Full Income Statement
Period Net Revenue Cost of Revenue Net Profit EPS
FY2022 Not reported yet.
Q32022
101.38M
+120.8%
15.04M
26.62M
+492.4%
$0.09
Q22022
45.92M
-85.5%
5.21M
-6.79M
-104%
$-0.02
Q12022
316.58M
44.64M
168.57M
$0.59
FY2021
375.2M
 45.52M
153.46M
$0.96
Q42021
139.33M
+2429.6%
21.89M
59.95M
+380.4%
$0.21
Q32021
5.51M
-80.1%
0
-21.38M
-820.4%
$-0.08
Q22021
27.64M
-86.4%
3.61M
-2.32M
-102%
$-0.01
Q12021
202.74M
20.01M
117.22M
$0.43
FY2020
233.16M
 27.14M
118.92M
$0.53
FY2019
11.61M
 0
-2.21M
$-0.01
FY2018
8.83M
 0
308.85k
$0
Balance Sheet
Full Balance Sheet
Period Total Assets Total Liabilities Cash & Eq. Debt Stock Equity
FY2022 Not reported yet.
Q32022
1.55B
 302.24M
371.97M
76.11M
1.25B
Q22022
1.59B
 380.93M
790.62M
36.78M
1.21B
Q12022
1.59B
 384.78M
545.72M
40.28M
1.21B
FY2021
1.32B
 292.84M
476.14M
36.41M
1.03B
FY2020
1.01B
 175.03M
594.12M
3.93M
830.51M
FY2019
23.49M
 13.24M
7.55M
7.14M
10.25M
FY2018
21.49M
 9.88M
10.44M
5.97M
11.61M
Cash Flow Statement
Full Cash Flow Statement
Period Operating CF Investing CF Financing CF Capex Free Cash Flow
FY2022 Not reported yet.
Q32022
-126.79M
 -281.99M
-19k
-14.51M
-141.3M
-158.5%
Q22022
273.02M
 -27.2M
1.17M
-31.32M
241.69M
+181.9%
Q12022
100.22M
 -26.37M
-3.13M
-14.5M
85.72M
FY2021
244.58M
 -332.25M
-3.89M
-58.45M
186.13M
FY2020
22.69M
 -119.78M
683.65M
-14.67M
8.02M
FY2019
2.69M
 -5.78M
194.83k
-4M
-1.3M
FY2018 No data.
Institutional Ownership
Dividend History
No dividend history.
Number of Employees